Your browser doesn't support javascript.
loading
ECFS best practice guidelines: the 2018 revision.
Castellani, Carlo; Duff, Alistair J A; Bell, Scott C; Heijerman, Harry G M; Munck, Anne; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Southern, Kevin W; Barben, Jurg; Flume, Patrick A; Hodková, Pavla; Kashirskaya, Nataliya; Kirszenbaum, Maya N; Madge, Sue; Oxley, Helen; Plant, Barry; Schwarzenberg, Sarah Jane; Smyth, Alan R; Taccetti, Giovanni; Wagner, Thomas O F; Wolfe, Susan P; Drevinek, Pavel.
Afiliación
  • Castellani C; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, Italy; Cystic Fibrosis Centre, Gaslini Institute, Genoa, Italy.
  • Duff AJA; Regional Paediatric CF Unit, Leeds General Infirmary Leeds, UK; Department of Clinical & Health Psychology, St James' University Hospital, Leeds, UK. Electronic address: alistair.duff1@nhs.net.
  • Bell SC; Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Australia.
  • Heijerman HGM; Dept of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Munck A; Hopital Robert Debré Assistante publique-Hôpitaux de Paris, Université Paris 7, Pediatric CF Centre, Paris, France.
  • Ratjen F; Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Canada.
  • Sermet-Gaudelus I; Service de Pneumologie et Allergologie Pédiatriques, Centre de Ressources et de Compétence de la Mucoviscidose, Institut Necker Enfants Malades/INSERM U1151 Hôpital Necker Enfants Malades, P, France.
  • Southern KW; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Barben J; Ostschweizer Kinderspital Sankt Gallen, Claudiusstrasse 6, 9006 St. Gallen, Switzerland.
  • Flume PA; Division of Pulmonary and Critical Care, Medical University of South Carolina, USA.
  • Hodková P; Department of Clinical Psychology, University Hospital, Prague, Czech Republic.
  • Kashirskaya N; Department of Genetic Epidemiology (Cystic Fibrosis Group), Federal State Budgetary Institution, Research Centre for Medical Genetics, Moscow, Russia.
  • Kirszenbaum MN; Department of Pediatric Pulmunology, CRCM, Hôpital Necker-Enfants Malades, Paris, France.
  • Madge S; Cystic Fibrosis Centre, Royal Brompton Hospital, London, UK.
  • Oxley H; Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.
  • Plant B; Cork Adult CF Centre, Cork University Hospital, University College, Cork, Republic of Ireland.
  • Schwarzenberg SJ; Divison of Pediatric Gastroenterology Hepatology and Nutrition, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.
  • Smyth AR; Division of Child Health, Obstetrics & Gynaecology (COG), University of Nottingham, Nottingham, UK.
  • Taccetti G; Cystic Fibrosis Centre, Department of Paediatric Medicine, Anna Meyer Children's University Hospital, Florence, Italy.
  • Wagner TOF; Frankfurter Referenzzentrum für Seltene Erkrankungen (FRZSE), Universitätsklinikum Frankfurt am Main, Wolfgang von Goethe-Universität, Frankfurt am Main, Germany.
  • Wolfe SP; Regional Paediatric CF Unit, The Leeds Children's Hospital, Leeds Teaching Hospitals, Belmont Grove, Leeds, UK.
  • Drevinek P; Department of Medical Microbiology, Faculty of Medicine, Motol University Hospital, Prague, Czech Republic.
J Cyst Fibros ; 17(2): 153-178, 2018 03.
Article en En | MEDLINE | ID: mdl-29506920
Developments in managing CF continue to drive dramatic improvements in survival. As newborn screening rolls-out across Europe, CF centres are increasingly caring for cohorts of patients who have minimal lung disease on diagnosis. With the introduction of mutation-specific therapies and the prospect of truly personalised medicine, patients have the potential to enjoy good quality of life in adulthood with ever-increasing life expectancy. The landmark Standards of Care published in 2005 set out what high quality CF care is and how it can be delivered throughout Europe. This underwent a fundamental re-write in 2014, resulting in three documents; center framework, quality management and best practice guidelines. This document is a revision of the latter, updating standards for best practice in key aspects of CF care, in the context of a fast-moving and dynamic field. In continuing to give a broad overview of the standards expected for newborn screening, diagnosis, preventative treatment of lung disease, nutrition, complications, transplant/end of life care and psychological support, this consensus on best practice is expected to prove useful to clinical teams both in countries where CF care is developing and those with established CF centres. The document is an ECFS product and endorsed by the CF Network in ERN LUNG and CF Europe.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Guideline Aspecto: Patient_preference Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Europa Idioma: En Revista: J Cyst Fibros Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Guideline Aspecto: Patient_preference Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Europa Idioma: En Revista: J Cyst Fibros Año: 2018 Tipo del documento: Article País de afiliación: Italia
...